GALMED PHARMACEUTICALS LTD. Proceeds from Other Equity
GALMED PHARMACEUTICALS LTD. (GLMD) reported Proceeds from Other Equity of $1.36 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromOtherEquity · last filed 2026-09-02
- GALMED PHARMACEUTICALS LTD. proceeds from other equity for the quarter ending 2025-12-31 was -$6.31M, a 1508.04% decline year-over-year.
- GALMED PHARMACEUTICALS LTD. proceeds from other equity for the quarter ending 2025-09-30 was $190.00K.
- GALMED PHARMACEUTICALS LTD. proceeds from other equity for the quarter ending 2024-12-31 was $448.00K.
| Period end | Proceeds from Other Equity 3 month | Proceeds from Other Equity 6 month | Proceeds from Other Equity 9 month | Proceeds from Other Equity 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$6.31M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-31 | -$6.12M derived: sum of 2 quarters · filed 2026-03-31 | $1.36M 20-F · filed 2026-03-31 | |
| 2025-09-30 | $190.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-26 | $7.66M 6-K · filed 2025-11-26 | ||
| 2025-06-30 | $7.47M 6-K · filed 2026-09-02 | |||
| 2024-12-31 | $448.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-31 | $4.39M 20-F · filed 2026-03-31 | ||
| 2024-09-30 | $3.94M 6-K · filed 2025-11-26 | |||
| 2016-12-31 | $4.48M 20-F · filed 2017-03-23 | |||
| 2015-12-31 | $0.00 20-F · filed 2017-03-23 | |||
| 2014-12-31 | $0.00 20-F · filed 2017-03-23 |